NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Your BS has literally no boundaries.

The company hiding an MHRA rejection based on the excuse that "Form 8-K doesn't specifically mention MHRA rejections," is ignoring the core of SEC compliance. A regulatory rejection is inherently material and must be disclosed immediately to protect investors from trading on inaccurate information. This news would almost certainly cause a significant drop in the stock price. Therefore, the company must disclose it immediately because it materially impacts the value of the securities. Whether it's "good" or "bad" is secondary to its financial and investment consequences.

SEC Rule 10b-5 (The Anti-Fraud Provision)
This is the ultimate "catch-all" rule that renders the claim that Form 8-K is an exhaustive list completely incorrect.

The Rule: Rule 10b-5 makes it unlawful for any person: (b) To make any untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading, or...

The Duty to Correct: If a company previously issued positive statements about DCVAXL's progress, and the MHRA rejects it, withholding the rejection is the omission of a material fact that makes their prior statements misleading. The duty to correct that information is immediate.

and thats just 2 SEC reasons why your claiim is BS
Clown.